Future of Microfluidic Immunoassay Market Growth
Meticulous Research®—a leading global market research company, published a research report titled Microfluidic Immunoassay Market Size, Share, Forecast, & Trends Analysis by Product (Cartridge [Polymer, Glass], Reagent, System) Technology (Electrochemical, Optical) Application (Cardiology, Oncology, Infectious Disease) End User—Global Forecast to 2031.’
According to this latest
publication from Meticulous Research®, the global microfluidic
immunoassay market is projected to reach $1.59
billion by 2031 at a CAGR of 7.3% from 2024 to 2031. The growth of this market is driven by
the increasing use of microfluidic immunoassays in drug discovery &
development and biomarker detection, the advantages of lab-on-chip immunoassays
over conventional immunoassays, pharmaceutical & biotechnology companies'
increasing focus on research & development, and the miniaturization of
biological and chemical assays. However, bubble formation and dead volume in
microfluidics devices restrain the growth of this market.
Moreover, the increasing demand for
point-of-care diagnostics and recent advancements in microfluidic immunoassay
technology are expected to generate market growth opportunities. However, the
selection of suitable substrate materials for designing microfluidic chips and
product design and cost-related limitations in developing countries are major
challenges for market stakeholders.
Key Players
The key players operating in the
global microfluidic immunoassay market are Becton, Dickinson and Company
(U.S.), Revvity, Inc. (U.S.), Abbott Laboratories (U.S.), Siemens Healthineers
AG (Germany), Nanomix Corporation (U.S.), Micropoint Biotechnologies Co., Ltd.
(China), Biosurfit SA (Portugal), Koninklijke Philips N.V. (Netherland),
NanoEnTek Inc. (South Korea), and QuidelOrtho Corporation (U.S.)
Microfluidic Immunoassay Market:
Future Outlook
The global microfluidic immunoassay
market is segmented by Product (Consumables [Cartridges {Polymer, Glass, and
Silicon} and Reagents] and Systems), Technology (Electrochemical Detection and
Optical Detection), Application (Cardiology (Single Biomarker Detection and
Multiplexed Biomarker Detection), Infectious Diseases, Oncology, and Other
Applications), End User (Pharmaceutical & Biotechnology Companies,
Diagnostic Laboratories, Hospitals, and Other End Users), and Geography. The
study also evaluates industry competitors and analyzes their market share at
global and regional levels.
Among all products studied in this
report, the consumables
segment is expected to grow at the highest CAGR during the forecast period. The
continuous advancements in the development of reagents and kits, the adoption
of microfluidic immunoassay diagnostic kits for disease diagnosis, and ease of
use are increasing the demand for consumables used in the microfluidic
immunoassay market, driving its growth.
Among all technologies studied in
this report, in 2024, the
electrochemical detection segment is expected to account for the largest share
of the microfluidic immunoassay market. The large market share of this segment
is attributed to factors such as the increasing adoption of electrochemical detection
in point-of-care testing, adaptability for miniaturization, rapid detection,
and low-cost methods.
Among all applications studied in
this report, the oncology
segment is expected to grow at the highest CAGR during the forecast period. The
highest CAGR of this segment is attributed to pharmaceutical &
biotechnology research organizations using microfluidic immunoassay for
oncology biomarker detection in research applications, such as anti-cancer drug
studies, drug discoveries, and personalized medicine.
Among all end users studied in this
report, in 2024, the
pharmaceutical and biotechnology companies segment is expected to account for
the largest share of the microfluidic immunoassay market. The largest share of
this segment is attributed to the increasing demand for new drugs and
therapies, leading to extensive research and development activities, rising
funding and investments in the pharmaceutical and biotech industry, and
increasing healthcare expenditure. Furthermore, the pharmaceutical and
biotechnology industries constantly strive to develop new drugs and therapies
to address medical needs, further driving market growth.
This research report analyzes major
geographies and provides a comprehensive analysis of North America (U.S. and
Canada), Europe (Germany, France, U.K., Italy, Spain, and the Rest of Europe),
Asia-Pacific (China, Japan, India, and the Rest of Asia-Pacific), Latin
America, and the Middle East & Africa.
Among all regions studied in this
report, Asia-Pacific is expected to grow at the highest CAGR during the
forecast period. The highest CAGR of the region is attributed to advancements
in healthcare infrastructure, development in the R&D sector, increasing
number of diagnostic laboratories in the region, and advancements in the
research sector in emerging economies of the region.
Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5034
Key questions answered in the
report:
·
Which are
the high-growth market segments in terms of product, technology, application,
end user, and regions/countries?
·
What was
the historical market for microfluidic immunoassay across the globe?
·
What are
the market forecasts and estimates for the period 2024–2031?
·
What are
the major drivers, restraints, challenges, opportunities, and trends in the
global microfluidic immunoassay market?
·
Who are
the major players in the global microfluidic immunoassay market?
·
What is
the competitive landscape, and who are the market leaders in the global
microfluidic immunoassay market?
·
What are
the recent developments in the microfluidic immunoassay market?
·
What are
the different strategies adopted by the major players in the microfluidic
immunoassay market?
·
What are
the geographical trends and high-growth regions/countries?
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Comments
Post a Comment